» Articles » PMID: 30564628

Optical Coherence Tomography Features in Brothers with Aspartylglucosaminuria

Overview
Specialty Neurology
Date 2018 Dec 20
PMID 30564628
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Aspartylglucosaminuria is a lysosomal storage disorder enriched in Finland. We report on a pair of non-Finnish siblings with aspartylglucosaminuria with autofluorescent inclusion bodies on optical coherence tomography, a finding not previously reported in this disorder. We performed a record review, neurological and neuropsychological evaluation, brain MRI, and optical coherence tomography for each patient. They are compound heterozygous for a 34-kb deletion and a c.365C>A novel variant of the gene. Autofluorescent inclusion bodies were found on optical coherence tomography in the older, more severely affected brother. We hypothesize the finding represents a noninvasive biomarker of disease severity for aspartylglucosaminuria.

Citing Articles

A cross-sectional natural history study of aspartylglucosaminuria.

Goodspeed K, Horton D, Lowden A, Sguigna P, Booth T, Wang Z JIMD Rep. 2022; 63(5):425-433.

PMID: 36101820 PMC: 9458605. DOI: 10.1002/jmd2.12294.

References
1.
Autti T, Lonnqvist T, Joensuu R . Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria. Acta Radiol. 2008; 49(6):687-92. DOI: 10.1080/02841850802065000. View

2.
Abalem M, Francischini S, Carricondo P, Graziano R . Fundus autofluorescence in Tay-Sachs disease. JAMA Ophthalmol. 2014; 132(7):876. DOI: 10.1001/jamaophthalmol.2013.5700. View

3.
Tokola A, Aberg L, Autti T . Brain MRI findings in aspartylglucosaminuria. J Neuroradiol. 2015; 42(6):345-57. DOI: 10.1016/j.neurad.2015.03.003. View

4.
Nolan R, Narayana K, Galetta S, Balcer L . Optical Coherence Tomography for the Neurologist. Semin Neurol. 2015; 35(5):564-77. DOI: 10.1055/s-0035-1563579. View

5.
Dulz S, Wagenfeld L, Nickel M, Richard G, Schwartz R, Bartsch U . Novel morphological macular findings in juvenile CLN3 disease. Br J Ophthalmol. 2015; 100(6):824-8. DOI: 10.1136/bjophthalmol-2015-307320. View